(2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide

C31H54N4O3 — CID 71001148

IUPAC(2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide
SMILESCN(C)CCNC(=O)[C@@H]1C[C@H](NC(=O)CCC2CCC3C4CCC5C[C@H](O)CC[C@]5(C)C4CC[C@]23C)CN1
InChIInChI=1S/C31H54N4O3/c1-30-14-12-26-24(8-5-21-17-23(36)11-13-31(21,26)2)25(30)9-6-20(30)7-10-28(37)34-22-18-27(33-19-22)29(38)32-15-16-35(3)4/h20-27,33,36H,5-19H2,1-4H3,(H,32,38)(H,34,37)/t20?,21?,22-,23+,24?,25?,26?,27-,30+,31-/m0/s1
InChIKeyRIJCJWHSMREKSX-UPSWWROOSA-N
MW530.80 g/mol
LogP3.31
Rot. Bonds8

About (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide

(2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide (PubChem CID 71001148) has the molecular formula C31H54N4O3 and a molecular weight of 530.80 g/mol. Its IUPAC name is (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide.

Molecular Properties

Compound Name(2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide
PubChem CID71001148
Molecular FormulaC31H54N4O3
Molecular Weight530.80 g/mol
Exact Mass530.42
IUPAC Name(2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide
SMILESCN(C)CCNC(=O)[C@@H]1C[C@H](NC(=O)CCC2CCC3C4CCC5C[C@H](O)CC[C@]5(C)C4CC[C@]23C)CN1
InChIInChI=1S/C31H54N4O3/c1-30-14-12-26-24(8-5-21-17-23(36)11-13-31(21,26)2)25(30)9-6-20(30)7-10-28(37)34-22-18-27(33-19-22)29(38)32-15-16-35(3)4/h20-27,33,36H,5-19H2,1-4H3,(H,32,38)(H,34,37)/t20?,21?,22-,23+,24?,25?,26?,27-,30+,31-/m0/s1
InChIKeyRIJCJWHSMREKSX-UPSWWROOSA-N
XLogP3.31
TPSA93.70 Ų
H-Bond Donors4
H-Bond Acceptors5
Rotatable Bonds8
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500530.80
LogP ≤ 53.31
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 105

Analyze (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide?
The IUPAC name of (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide (CID 71001148) is (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide.
What is the SMILES notation for (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide?
The canonical SMILES for (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide is CN(C)CCNC(=O)[C@@H]1C[C@H](NC(=O)CCC2CCC3C4CCC5C[C@H](O)CC[C@]5(C)C4CC[C@]23C)CN1.
What is the InChIKey of (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide?
The InChIKey is RIJCJWHSMREKSX-UPSWWROOSA-N. The full InChI is InChI=1S/C31H54N4O3/c1-30-14-12-26-24(8-5-21-17-23(36)11-13-31(21,26)2)25(30)9-6-20(30)7-10-28(37)34-22-18-27(33-19-22)29(38)32-15-16-35(3)4/h20-27,33,36H,5-19H2,1-4H3,(H,32,38)(H,34,37)/t20?,21?,22-,23+,24?,25?,26?,27-,30+,31-/m0/s1.
What are the key properties of (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide?
(2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide has a molecular weight of 530.80 g/mol, XLogP of 3.31, 8 rotatable bonds, 4 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,4S)-N-[2-(dimethylamino)ethyl]-4-[3-[(3R,10S,13R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoylamino]pyrrolidine-2-carboxamide is sourced from PubChem (CID 71001148), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).